- Gastroesophageal reflux disease (GERD)
- Acid-related disorders
- Peptic ulcer disease
- Prevention/treatment of certain acid-related complications
- Hypersecretory conditions as prescribed
ERRSOME-40 contains Esomeprazole, a proton pump inhibitor (PPI) that reduces gastric acid secretion. The injectable formulation is used when oral administration is not suitable or when specifically indicated.
Indicated for acid-related gastrointestinal conditions requiring Esomeprazole therapy and, where appropriate, injectable administration.
For IV administration only under the supervision of a qualified healthcare professional. Dose and duration should be determined by the physician.
Headache, nausea, abdominal discomfort, diarrhea, constipation and injection-site reactions may occur.
Store in a cool, dry place protected from direct sunlight. Do not freeze. Reconstituted solution should be used according to the manufacturer’s instructions.
Product information is provided for professional and informational purposes. Please refer to the approved product labeling and applicable professional guidance for appropriate use.